Making end-of-life and palliative care viable in India: A blueprint for action.

Natl Med J India

Karunashraya Hospice, Bangalore Hospice Trust, Bengaluru, Karnataka, India.

Published: July 2020

Download full-text PDF

Source
http://dx.doi.org/10.4103/0970-258X.278684DOI Listing

Publication Analysis

Top Keywords

making end-of-life
4
end-of-life palliative
4
palliative care
4
care viable
4
viable india
4
india blueprint
4
blueprint action
4
making
1
palliative
1
care
1

Similar Publications

Aim: To carry out a detailed study of existing positions in the French public of the acceptability of refusing treatment because of alleged futility, and to try to link these to people's age, gender, and religious practice.

Method: 248 lay participants living in southern France were presented with 16 brief vignettes depicting a cancer patient at the end of life who asks his doctor to administer a new cancer treatment he has heard about. Considering that this treatment is futile in the patient's case, the doctor refuses to prescribe it.

View Article and Find Full Text PDF

Telomerase in cancer- ongoing quest and future discoveries.

Mol Biol Rep

January 2025

Department of Integrative Biology, School of Bio-Sciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, 632014, India.

Telomerase, constituted by the dynamic duo of telomerase reverse transcriptase (TERT), the catalytic entity, and an integral RNA component (TERC), is predominantly suppressed in differentiated human cells due to postnatal transcriptional repression of the TERT gene. Dysregulation of telomerase significantly contributes to cancer development via telomere-dependent and independent mechanisms. Telomerase activity is often elevated in advanced cancers, with TERT reactivation and upregulation of TERC observed in early tumorigenesis.

View Article and Find Full Text PDF

This paper presents a novel rail-to-rail Class-AB operational amplifier tailored for wake-up systems in motion sensor applications. By addressing limitations in free Class-AB designs, such as large inrush current, unstable bias conditions, and area ineffiiency, the proposed design achieves a gain of 59 dB and unity gain frequency of 550 kHz driving a 5 pF load. The inrush current is reduced from 1 mA to 7 µA, increasing the battery life.

View Article and Find Full Text PDF

Purpose: is the main etiologic agent implicated in primary amoebic meningoencephalitis (PAM). It is also known as the brain-eating amoeba because of the severe brain inflammation following infection, with a survival rate of about 5%. This review aims to identify infections and evaluate patients' progression.

View Article and Find Full Text PDF

Acute lymphoblastic leukemia (ALL) is a malignant condition of lymphoid progenitor cells that primarily affects the pediatric population, but also adults. The 5-year survival rate is 90% in children and approximately 40% in adults, with survival increasing through the use of peripheral stem cell allotransplantation (SCT). The relapse rate after stem cell transplantation (SCT) in adult acute lymphoblastic leukemia (ALL) patients ranges from 35% to 45%, making relapse a major cause of death in this population.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!